PRF Technologies Ltd. 宣布PRF-110实现罗哌卡因单方、无NSAID配方的持续镇痛效果

美股速递
May 26

PRF Technologies Ltd. 近日公布,其研发的PRF-110在镇痛领域取得重要进展。该产品采用仅含罗哌卡因、不含非甾体抗炎药(NSAID)的创新配方,成功实现了持续的镇痛效果。

这一突破性配方旨在提供长效的疼痛缓解,同时避免了传统镇痛方案中常伴随NSAID可能引发的相关风险。公司表示,该成果标志着其在局部镇痛药物开发方面迈出了关键一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10